The Cooper Companies, Inc. COO
NASDAQ · Healthcare · Medical - Instruments & Supplies
$58.88
Close on Fri, 20 Nov 2026 · market value $11.2B
What the price is betting on
Below its recordAt $59, the price assumes revenue grows about 1% a year for five years, from $4.2B to about $4.4B by FY2030. That is less than what analysts expect for the next two years and less than the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 8.4% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than COO? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$62
Base
$69
Bull
$77
Today $59
- Bear $62. Cash flow grows 2% a year for the next 5 years, slower than expected, then slows to long-run growth.
- Base $69. Cash flow grows 4% a year for the next 5 years, as analysts expect, then slows to long-run growth.
- Bull $77. Cash flow grows 6% a year for the next 5 years, faster than expected, then slows to long-run growth.
Stories set by rules from the company’s record.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2026$4.2B$4.2B, on the path
- FY2027$4.3B$4.4B, on the path
- FY2028$4.3B$4.6B, on the path
- FY2029$4.4B$4.9B, on the path
- FY2030$4.4B$5.2B, on the path
Each year's revenue at 1% growth from $4.2B in the 12 months to July 2026.
At a glance
Healthcare · Medical - Instruments & Supplies · listed on NASDAQ
- Revenue, FY2025
- $4.1B
- Growth, 3 years a year
- 6.2%
- Cash margin
- 11%
- Net debt
- $2.7B
- Shares, 3-year change
- +0.6%
- Dividend yield
- 0%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.